deferoxamine has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caltagirone, A; Chahine, D; Fillebeen, C; Pantopoulos, K; Segal, P | 1 |
| Brüne, B; Callapina, M; Deitmer, JW; Lohr, C; Metzen, E; Schnitzer, S; Zhou, J | 1 |
| Baumann, MU; Illsley, NP; Zamudio, S | 1 |
| Faurschou, A; Gniadecki, R | 1 |
| Lai, Y; Qiao, M; Shiio, Y; Song, M; Weintraub, ST | 1 |
| Wang, Z; Yin, D; Zhang, Z | 1 |
| Bouchecareilh, M; Hutt, DM; Marchal, C; Roth, DM | 1 |
7 other study(ies) available for deferoxamine and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
A phosphomimetic mutation at Ser-138 renders iron regulatory protein 1 sensitive to iron-dependent degradation.
Topics: Acetylcysteine; Amino Acid Sequence; Animals; Cell Line; Cysteine Proteinase Inhibitors; Deferoxamine; Humans; Iron; Iron Chelating Agents; Iron Regulatory Protein 1; Leupeptins; Mice; Molecular Sequence Data; Mutation; Point Mutation; Recombinant Proteins; Sequence Homology, Amino Acid; Serine | 2003 |
Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
Topics: Amino Acids, Dicarboxylic; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Cysteine Proteinase Inhibitors; Deferoxamine; Enzyme Inhibitors; Ferric Compounds; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Iron; Leupeptins; Nitric Oxide; Nitric Oxide Donors; Procollagen-Proline Dioxygenase; Proteasome Endopeptidase Complex; Proteasome Inhibitors; S-Nitrosoglutathione; Transcription Factors; Triazenes; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein | 2005 |
Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1.
Topics: Actins; Cell Hypoxia; Cell Line, Tumor; Choriocarcinoma; Chorionic Villi; Cobalt; Cysteine Proteinase Inhibitors; Deferoxamine; Dose-Response Relationship, Drug; Female; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Oligonucleotides, Antisense; Pregnancy; Proteasome Endopeptidase Complex; Receptors, Transferrin; Time Factors; Tissue Culture Techniques; Trophoblasts; Up-Regulation | 2007 |
TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes.
Topics: Acetylcysteine; Androstadienes; Apoptosis; Blotting, Western; Caspases; Cell Line; Cell Survival; Chromones; Deferoxamine; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Keratinocytes; Leupeptins; Morpholines; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Tocopherols; Tumor Necrosis Factor-alpha; Wortmannin | 2008 |
Quantitative proteomics identifies the Myb-binding protein p160 as a novel target of the von Hippel-Lindau tumor suppressor.
Topics: Animals; BALB 3T3 Cells; Carrier Proteins; Cells, Cultured; Deferoxamine; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Isotope Labeling; Leupeptins; Mice; Models, Biological; Nuclear Proteins; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Proteomics; RNA-Binding Proteins; Siderophores; Transcription Factors; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein | 2011 |
Contribution of hypoxia-inducible factor-1α to transcriptional regulation of vascular endothelial growth factor in bovine developing luteal cells.
Topics: Animals; Blotting, Western; Cattle; Cell Hypoxia; Cobalt; Deferoxamine; Female; Ferrous Compounds; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Luteal Cells; Oligodeoxyribonucleotides; Quaternary Ammonium Compounds; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Transcriptional Activation; Vascular Endothelial Growth Factor A | 2011 |
Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Topics: Acetylation; Blotting, Western; Cell Line, Tumor; Chromatin; Chromosomal Proteins, Non-Histone; Cyclin D1; Deferoxamine; Eukaryotic Initiation Factor-3; Gene Expression Regulation, Neoplastic; Glycine; Hepatocytes; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Protein Biosynthesis; Protein Processing, Post-Translational; RNA, Small Interfering; Vorinostat | 2017 |